Jeff Burris serves as Chief Legal Officer at Indivior Pharmaceuticals Inc., a global pharmaceutical company dedicated to addressing opioid use disorder and serious mental health conditions. In this pivotal role, Burris oversees all legal functions, including regulatory compliance, intellectual property protection, corporate governance, and litigation strategy. He plays a critical part in navigating the complex regulatory landscape of the pharmaceutical industry, ensuring Indivior's innovative treatments, such as SUBLOXONE and PERSERIS, reach patients while mitigating legal risks in a highly scrutinized sector. With more than 25 years of experience in healthcare law, Burris began his career at a leading New York law firm, where he specialized in FDA regulatory matters and pharmaceutical patent litigation. He advanced to partner before transitioning to executive roles at major biopharmaceutical companies, including stints at Purdue Pharma and Teva Pharmaceuticals, where he led successful defenses in multibillion-dollar opioid-related lawsuits and secured key regulatory approvals for novel delivery systems. Among his notable achievements, Burris orchestrated a landmark settlement that resolved long-standing patent disputes, saving his prior employer over $500 million, and advised on multiple cross-border mergers that expanded market access in Europe and Asia. At Indivior, Burris has been instrumental in strengthening the company's legal framework amid evolving U.S. healthcare policies, fostering partnerships with government agencies, and driving ethical compliance initiatives that align with the company's mission to combat addiction. His strategic foresight has supported Indivior's growth, positioning it as a leader in addiction treatment innovation.